BMO Capital Markets analysts Tamy Chen, CFA, and Peter Sklar, CPA, CA, recently initiated coverage of The Supreme Cannabis Company at Market Perform with a C$2.50 per share price target, representing a 15 percent premium to the then-current market price. The analyst sees the potential for a C$3.00 share price with brand traction, accelerating sales, ramping production, and strategic international acquisitions.

I found the target (2,50) a little low.  3,25-50$ being more likely when looking at the fundamentals